This inventor holds 2 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Naoki Yoshihara: Innovator in Pharmaceutical Granulation
Introduction
Naoki Yoshihara is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical granulation, holding a total of 2 patents. His work focuses on methods that enhance the production and effectiveness of pharmaceutical compositions.
Latest Patents
Yoshihara's latest patents include a method for producing granules containing a core particle, as well as the granules themselves. These innovations aim to improve pharmaceutical compositions by utilizing a general granulation method. The method involves spraying a granulation liquid with a mist diameter not exceeding the particle size of the core particle onto a mixture containing a drug substance. This technique allows for the creation of granules that can effectively mask bitterness, enhancing the overall patient experience.
Career Highlights
Yoshihara is associated with Sawai Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His innovative approaches have contributed to advancements in drug formulation and delivery systems. His work is recognized for its potential to improve the efficacy and palatability of medications.
Collaborations
Yoshihara has collaborated with notable colleagues, including Ryota Kimata and Wataru Izui. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical industry.
Conclusion
Naoki Yoshihara's contributions to pharmaceutical granulation exemplify the importance of innovation in drug development. His patents reflect a commitment to improving patient outcomes through effective formulation techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
